LOGIN
AAOS 2022: Buccally Absorbed Cannabidiol for Pain After Arthroscopic Rotator Cuff Repair
May 2022
AAOS 2022: Buccally Absorbed Cannabidiol for Pain After Arthroscopic Rotator Cuff Repair
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Buccally Absorbed Cannabidiol Shows Promise in Treating Pain and Improving Satisfaction Immediately Following Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, DoubleBlinded, Randomized Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
100 patients undergoing arthroscopic rotator cuff repair were randomized to receive 14 days of oral, buccally absorbed cannabidiol (CBD; 25mg [<80kg] or 50mg [>80kg], three times per day) or placebo. Outcomes of interest included Visual Analog Scale (VAS) for pain, opioid consumption, satisfaction with pain control, liver function, and nausea, assessed up to 14 days follow up. Cannabidiol result i...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.